Prenatal and postnatal management of hyperprostaglandin e syndrome after genetic diagnosis from amniocytes

Pediatrics

Volumn 103, Issue 3, 1999, Pages 678-683

  Köckerling, Arnold ^a  

^a Med Zentrum für Kinderheilkunde   (Germany)

Author keywords

Bartter syndrome; Hyperprostaglandin E syndrome; Indomethacin; ROMK

Indexed keywords

INDOMETACIN; PROSTAGLANDIN E;

AMNION CELL; ARTICLE; BARTTER SYNDROME; CYTOGENETICS; DISEASE COURSE; ELECTROLYTE BALANCE; FEMALE; FETUS; GENE MUTATION; HETEROZYGOSITY; HUMAN; HYDRAMNIOS; MATERNAL TREATMENT; PERINATAL PERIOD; PREMATURITY; PRENATAL SCREENING; PRIORITY JOURNAL; PROSTAGLANDIN URINE LEVEL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SYNDROME; TREATMENT PLANNING;

AMNIOTIC FLUID; BARTTER SYNDROME; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; KIDNEY; MALE; POLYHYDRAMNIOS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; POTASSIUM CHANNELS; PREGNANCY; PRENATAL DIAGNOSIS; PROSTAGLANDINS E; SYNDROME;

EID: 17344392679     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.103.3.678     Document Type: Article

References (38)

1. McCredie DA, Rotenberg E, Williams AL. Hypercalciuria in potassiumlosing nephropathy: a variant of Bartter's syndrome. Aust Paediatr J. 1974;10:286-295
2. Seyberth HW, Rascher W, Schweer H, Kühl PG, Mehls O, Schärer K. Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr. 1985;107:694-701
3. Deschenes G, Burguet A, Guyot C, et al. Forme anténatale du syndrome de Bartter. Ann Pédiatr. 1993;40:95-101
4. Seyberth HW, Soergel M, Köckerling A. Hypokalaemic tubular disorders: the hyperprostaglandin E syndrome and Gitelman-Bartter syndrome. In: Davison AM, Cameron JS, Grünfeld JP, Kerr DNS, Ritz E, Winearls CG, eds. Oxford Textbook of Clinical Nephrology. 2nd ed. Oxford, England: Oxford University Press; 1998:1085-1093
5. Ohlsson A, Sieck U, Cumming W, Akhtar M, Serenius F. A variant of Bartter's syndrome. Bartter's syndrome associated with hydramnios, prematurity, hypercalciuria and nephrocalcinosis. Acta Paediatr Scand. 1984;73:868-874
6. Proesmans W, Devlieger H, Van Assche A, et al. Bartter syndrome in two siblings - antenatal and neonatal observations. Int J Pediatr Nephrol. 1985;6:63-70
7. Köckerling A, Reinalter SC, Seyberth HW. Impaired response to furosemide in hyperprostaglandin E syndrome: evidence for a tubular defect in the loop of Henle. J Pediatr. 1996;129:519-528
8. Simon DB, Karet FE, Hamdan JM, Di Pietro A, Sanjad SA, Lifton RP. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nature Genet. 1996;13:183-188
9. + channel, ROMK. Nature Genet. 1996;14:152-156
10. Károlyi L, Konrad M, Köckerling A, et al. (International Collaborative Study Group for Bartter-like Syndromes). Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity. Hum Mol Genet. 1997;6:17-26
11. + channel function. Biochem Biophys Res Commun. 1997;203:641-645
12. Lang F, Rehwald W. Potassium channels in renal epithelial transport regulation. Physiol Rev. 1992;72:1-32
13. Orita M, Suzuki, YH, Sakiya T, Hayaski K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989;5:874-879
14. Samuelsson B, Granström E, Green K, Hamberg M, Hammarström S. Prostaglandins. Annu Rev Biochem. 1975;44:669-695
15. Levenson DJ, Simmons CE, Brenner BM. Arachidonic acid metabolism, prostaglandins and the kidney. Am J Med. 1982;72:354-374
16. Seyberth HW, Tulassay T, Kühl PG, Soeding K, Rascher W, Schweer H. Excretion of primary prostanoids and their metabolites during acute volume expansion. Prostaglandins. 1988;35:221-232
17. Schweer H, Watzer B, Seyberth HW. Determination of seven prostanoids in 1 mL of urine by gas chromatography-negative ion chemical ionization triple stage quatropole mass spectometry. J Chromatogr. 1994;B652:221-227
18. Moise KJ. Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. Am J Obstet Gynecol. 1993;168:1350-1353
19. Queenan JT, Thompson W, Whitfield CR, Shah SI. Amniotic fluid volumes in normal pregnancies. Am J Obstet Gynecol. 1972;114:34-38
20. Hoppe B, Hesse A, Neuhaus T, Fanconi S, Blau N, Roth B, Leumann E. Influence of nutrition on urinary oxalate and calcium in preterm and term infants. Pediatr Nephrol. 1997;11:687-690
21. Massa G, Proesmans W, Devlieger H, Vandenberghe K, Van Assche A, Eggermont E. Electrolyte composition of the amniotic fluid in Bartter syndrome. Eur J Obstet Gynecol Reprod Biol. 1987;24:335-340
22. Bonvalet JP, Pradelles P, Farman N. Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol. 1987;253:F377-F387
23. 2 metabolism in the human fetal membranes. Am J Obstet Gynerol. 1989;161:1580-1585
24. 2 on the fetal and maternal sides of intact fetal membranes. Acta Obstet Gynecol Scand. 1991;70:425-427
25. Kirshon B, Mari G, Moise KJ. Indomethacin therapy in the treatment of symptomatic polyhydramnios. Obstet Gynecol. 1990;75:202-205
26. Moise KJ, Huhta JC, Sharif DS, et al. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med. 1988;319:327-331
27. Norton ME, Merrill J, Cooper BAB, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl I Med. 1993;329:1602-1607
28. Rosenberg AA, Galan HL. Fetal drug therapy. Pediatr Clin North Am. 1997;44:113-135
29. Robillard JE, Smith FG, Smith FG Jr. Developmental aspects of renal function during fetal life. In: Edelmann CM Jr, ed. Pediatric Kidney Disease. 2nd ed. Boston, MA: Little, Brown and Company; 1992:3-18
30. Nakamura KT, Matherne GP, McWeeny OJ, Smith BA, Robillard JE. Renal hemodynamics and functional changes during transition from fetal to newborn life in sheep. Pediatr Res. 1987;21:229-234
31. Strauss J, Daniel SS, James LS. Postnatal adjustment in renal function. Pediatrics. 1981;68:802-808
32. Dear P, Newell SJ. Renal function in the newborn infant. In: Davison AM, Cameron JS, Grünfeld JP, Kerr DNS, Ritz E, Winearls CG, eds. Oxford Textbook of Clinical Nephrology. 2nd ed. Oxford, England: Oxford University Press; 1998:71-76
33. Mackie FE, Hodson EM, Roy LP, Knight JF. Neonatal Bartter syndrome-use of indomethacin in the newborn period and prevention of growth failure. Pediatr Nephrol. 1996;10:756-758
34. Marlow N, Chiswick ML. Neonatal Bartter's syndrome, indomethacin and necrotising enterocolitis. Acta Paediatr Scand. 1982:1031-1032
35. Radfar N, Gill JR, Bartter FC, Bravo E, Taylor AA, Bowden RE. Hypokalemia, in Bartter's syndrome and other disorders, produces resistance to vasopressors via prostaglandin overproduction. Proc Soc Biol Med. 1978;158:502-507
36. Dunn MJ. Prostaglandins and Bartter's syndrome. Kidney Int. 1981;19: 86-102
37. Schlatler E, Salomonsson M, Persson AEG, Greger R. Macula densa cells sense luminal NaCl concentration via the furosemide sensitive Na-2Cl-K cotransporter. Pfluegers Arch. 1989;414:286-290
38. Cameron JS, Greger R. Renal function and testing of function. In: Davison AM, Cameron JS, Grünfeld JP, Kerr DNS, Ritz E, Winearls CG, eds. Oxford Textbook of Clinical Nephrology. 2nd ed. Oxford, England: Oxford University Press; 1998:39-69